Key facts
- This page summarizes Ryan J. Watts's Form 4 filing for Denali Therapeutics Inc. (DNLI).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 08 Jan 2026, 16:20.
Ryan J. Watts - 06 Jan 2026 Form 4 Insider Report for Denali Therapeutics Inc. (DNLI)
- Reporting relationship
- President and CEO, Director
- Issuer ticker
- DNLI
- Reported as of
- 06 Jan 2026
- Net transaction value
- -$580,767
- SEC form
- 4
- Accepted by SEC
- 08 Jan 2026, 16:20:05 UTC
- Prior SEC filing
- 05 Jan 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Tyler Nielsen, by power of attorney
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Ryan J. Watts filed Form 4 for Denali Therapeutics Inc. (DNLI) on 08 Jan 2026.
Change
- Previous filing in this sequence was filed on 05 Jan 2026.
- Current net transaction value: -$580,767.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001724310
Primary reporting owner
Watts Ryan J.
- Relationship
- President and CEO, Director
- Address
- C/O DENALI THERAPEUTICS INC., 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO
- Signature
- /s/ Tyler Nielsen, by power of attorney
- Signature date
- 08 Jan 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DNLI
transaction
Common Stock
Sale
- Transaction value
- $580,767
- Shares
- -35,198
- Change %
- -11%
- Price
- $16.50
- Shares after
- 296,833
- Date
- 06 Jan 2026
- Ownership
- Direct
- Footnotes
- F1, F2
DNLI
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,152,604
- Date
- 06 Jan 2026
- Ownership
- See footnote
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested RSUs.
Footnote F2
Includes 184,915 Unvested RSUs.
Footnote F3
The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee.